Literature DB >> 17936322

Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.

R Karthikeyan1, S Karthigayan, M Sri Balasubashini, S T Somasundaram, T Balasubramanian.   

Abstract

The antitumor activity of the sea snake venom (Lapemis curtus) was evaluated against Ehrlich's ascites carcinoma (EAC) in Swiss albino mice and HeLa and Hep2 tumor cell cultures. Among the different doses tested, 6.50 microg/ml at 24 h was found to effectively inhibit cancer cell proliferation. The same dose on EAC-bearing mice by i.p. injection significantly reduced the tumor growth and was demonstrated by increased life span of the mice by 201.25%.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936322     DOI: 10.1016/j.toxicon.2007.08.012

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  3 in total

1.  Cytotoxic and apoptotic activities of black widow spiderling extract against HeLa cells.

Authors:  Xiaozhen Peng; Zhipan Dai; Qian Lei; Long Liang; Shuai Yan; Xianchun Wang
Journal:  Exp Ther Med       Date:  2017-04-27       Impact factor: 2.447

Review 2.  Therapeutic potential of snake venom in cancer therapy: current perspectives.

Authors:  Vivek Kumar Vyas; Keyur Brahmbhatt; Hardik Bhatt; Utsav Parmar
Journal:  Asian Pac J Trop Biomed       Date:  2013-02

3.  Bibliometric Analysis of Literature in Snake Venom-Related Research Worldwide (1933-2022).

Authors:  Fajar Sofyantoro; Donan Satria Yudha; Kenny Lischer; Tri Rini Nuringtyas; Wahyu Aristyaning Putri; Wisnu Ananta Kusuma; Yekti Asih Purwestri; Respati Tri Swasono
Journal:  Animals (Basel)       Date:  2022-08-12       Impact factor: 3.231

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.